Physician profile
John E Galt
NPI 1457483190
$668.63
in general payments reported to CMS, 2019-2025
10 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.08 · 2021: $96.69 · 2022: $89.46 · 2023: $144 · 2024: $123 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $144.31 | 2024-2025 | |
| Integra Lifesciences Corporation | $124.70 | 2022-2023 | Tcc-Ez |
| Kci USA, INC. | $111.53 | 2019-2023 | Activ.A.C. |
| Kerecis Limited | $97.69 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Medline Industries Lp | $96.69 | 2021 | |
| Davol INC. | $33.75 | 2019 | |
| Ovik Health, LLC | $17.39 | 2025 | Coflex Tlc |
| Molnlycke Health Care US, LLC | $14.80 | 2024 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Mepitel |
| Acell, INC. | $14.58 | 2019 | |
| Coloplast Corp | $13.19 | 2023 | Interdry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Galt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.